RGI-1001

N/A

Report date: 2025/01/26 18:51:44

Base Information

Drug NameRGI-1001
Drug Alias Namecedar pollen allergy (REGiMMUNE)RGI-1001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulatorsNKT cells modulators
TargetsNot applicable
Therapy Area/IndicationsHypersensitivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRegimmune Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRikenRegimmune Ltd
Inactive CompaniesN/A
Active IndicationsHypersensitivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A